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Abstract N-terminal acetylation is a protein modi¢cation com-
mon in eukaryotes, but rare in prokaryotes. Here, we charac-
terized ¢ve mammalian stathmin-like subdomains expressed in
Escherichia coli by matrix-assisted laser desorption/ionization
time-of-£ight mass spectrometry and nanoESI Q-TOF tandem
mass spectrometry. We revealed that RB3SLD and RB3PSLD are
NK-acetylated, whereas SCG10SLD and SCLIPSLD, although
identical up to residue 6, are not, as well as stathmin. To assess
the in£uence of the N-terminal sequences on NK-acetylation, we
exchanged residues 7 and 8 between acetylated RB3SLD and
unacetylated SCG10SLD, and showed that it reversed the acety-
lation pattern. Our results demonstrate that ectopic recombi-
nant proteins can be extensively NK-acetylated in E. coli, and
that the rules governing NK-acetylation are complex and involve
the N-terminal region, as in eukaryotes.
8 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Acetylation of the amino-terminal group of proteins is very
common in eukaryotes since 70% of soluble proteins is esti-
mated to bear this modi¢cation. It occurs either co-transla-
tionally or post-translationally, after the possible removal of
the N-terminal methionine. Although the widespread occur-
rence of NK-acetylation suggests an important biological role,
its exact function is not known. Several hypotheses have been
proposed, including an in£uence on protein stability (for re-
views see [1,2]).
The rules governing NK-acetylation are not clear, unlike
those governing the cleavage of the N-terminal methionine,
which are well de¢ned and conserved from prokaryotes to
higher eukaryotes. The removal of the N-terminal methionine
almost entirely depends on the nature of the second residue, a
small residue allowing the cleavage and a bulky one prevent-
ing it [3,4]. NK-acetylation in eukaryotes also primarily de-
pends on the nature of the second encoded residue: among
those which are found to be NK-acetylated, Ala and Ser
largely predominate (after N-terminal methionine cleavage),
as well as the uncleaved N-terminal Met when followed by
either Asp or Glu [5]. This speci¢city correlates with the iden-
ti¢cation of two classes of NK-acetyl transferase activities, one
acetylating substrates beginning with Ala/Ser/Thr/Gly, and
the other acetylating substrates beginning with Met (for a
review see [1]). However, systematic mutagenesis in several
model proteins reveals some variability in the in£uence of
the second encoded residue on NK-acetylation, depending on
the protein studied [4,6,7]. Other determinants likely contrib-
ute to de¢ne the speci¢city of NK-acetylation, also because not
all proteins bearing the preferred N-terminal residues are ace-
tylated. Experimental evidence exists that acetylation can be
in£uenced by at least the ¢rst six residues [7]. Moreover, a
computer analysis including about a hundred protein sequen-
ces suggests that the information contained in at least the ¢rst
40 residues may be necessary to distinguish between acetylated
and unacetylated proteins [8].
In prokaryotes, NK-acetylation is a much rarer event. We
found only ¢ve endogenous proteins reported to be NK-acety-
lated in Escherichia coli [9^12]. Moreover, eukaryotic proteins
which are normally acetylated endogenously are frequently
unacetylated when expressed in E. coli. In contrast, we report
here the mass spectrometric characterization of several re-
combinant proteins corresponding to subdomains of mamma-
lian stathmin family proteins, which we had expressed in
E. coli and puri¢ed in a previous study [13]. Unexpectedly,
two of them are NK-acetylated, whereas the others are not,
although they have very similar N-terminal sequences. Fur-
ther analysis of the NK-acetylation of two chimeric proteins
mutated on residues 7 and 8 give clues concerning the rules of
NK-acetylation in E. coli.
2. Materials and methods
2.1. Recombinant protein expression in E. coli
The stathmin-like domains (SLDs) of stathmin family proteins were
produced in E. coli BL21(DE3) and puri¢ed as described in [13,14].
The nucleotide triplets corresponding to residues 7 and 8 in
SCG10SLD and RB3SLD were mutated with the QuickChange site-di-
rected mutagenesis kit (Stratagene, La Jolla, CA, USA) and checked
by sequencing (Genome Express, Montreuil, France). The resulting
mutant proteins SCG10SLD-IE and RB3SLD-KQ (Table 2) were ex-
pressed and puri¢ed like the other proteins [13] except that the anion
exchange chromatography step was omitted.
2.2. Proteolysis
Extensive trypsin proteolysis of RB3SLD, RB3PSLD, and SCG10SLD-
IE was performed overnight at 37‡C in either 50 mM Tris^HCl, pH
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8.5, or phosphate-bu¡ered saline (PBS), pH 7.4, 1 mM EGTA, 1 mM
dithiothreitol (DTT), containing the recombinant protein (2.5 WM),
1 mM CaCl2 and trypsin 1/100 (w/w enzyme-to-substrate ratio). When
these conditions did not allow detection of the N-terminal peptides,
limited proteolysis conditions were optimized: SCG10SLD (2.5 WM)
was incubated overnight at 37‡C with trypsin 1/5000 in PBS, pH
7.4, 1 mM CaCl2, and RB3SLD-KQ (2.5 WM) was incubated for 2 h
at room temperature with GluC 1/5000 in PBS, pH 7.4, 1 mM EGTA,
1 mM DTT, after which the reactions were stopped by tri£uoroacetic
acid (TFA) at a ¢nal concentration of 1%.
2.3. N-terminal sequencing
Samples containing a mixture of 400 pmol stathmin and 400 pmol
of either RB3SLD or RB3PSLD in 20 Wl were desalted on a ProSorb
cartridge (Applied Biosystems) and sequenced by automated Edman
degradation using a Procise pulse-liquid protein sequencer (model
494, Perkin-Elmer Applied Biosystems Division, Foster City, CA,
USA).
2.4. Mass spectrometry characterization of recombinant proteins
The molecular masses of intact proteins were determined as de-
scribed in [13] by matrix-assisted laser desorption ionization time-of-
£ight mass spectrometry (MALDI-TOF MS) using a MALDI-TOF
mass spectrometer Voyager-STR biospectrometry workstation (Per-
septive Biosystems, Framingham, MA, USA). They were con¢rmed
by nano-electrospray ionization (nanoESI) quadrupole time-of-£ight
(Q-TOF) MS using a Q-TOF 2 mass spectrometer (Micromass, Man-
chester, UK), after desalting the samples on a C18 Zip-Tip (Millipore,
Bedford, MA, USA) eluted in methanol, water and acetic acid (50/50/
0.5).
Modi¢cations of the proteins were characterized by mass spectrom-
etry of the peptides resulting from their proteolysis. The peptide so-
lution was diluted to about 5 pmol/Wl in 0.5% TFA, and analyzed
after co-crystallization with a matrix of 2.5-dihydroxybenzoic acid
(saturated solution in 0.1% aqueous TFA) by MALDI-TOF MS in
the positive and re£ectron mode. The N-terminal peptides were iden-
ti¢ed by comparing experimental masses with the theoretical masses
of the non-modi¢ed peptides released from tryptic or Glu-C digestion
of the proteins. The position of the acetylated residue was determined
by tandem mass spectrometry analysis of the peptide bearing the
42 Da mass increment, using the Q-TOF 2 mass spectrometer.
3. Results
3.1. MALDI-TOF MS reveals a putative acetylation of
mammalian proteins expressed in E. coli
In a previous study, we expressed in E. coli and puri¢ed ¢ve
mammalian SLDs, which display 70^80% amino acid identity
along their sequence (about 140 residues) [13]. The molecular
masses of the expressed proteins were determined by MALDI-
TOF MS. For stathmin, SCG10SLD and SCLIPSLD, they cor-
responded to the values calculated for the proteins after
N-terminal methionine cleavage (Table 1). For RB3SLD and
RB3PSLD, the experimental masses were 43 and 43.9 Da larger
than expected, which suggested that these two splice variants,
identical up to residue 124, may bear an acetylation, respon-
sible for a 42 Da mass increment. The relative di¡erence be-
tween the experimental mass determination and the calculated
average mass plus 42 Da (0.006% and 0.013%) is consistent
with the accuracy of MALDI-TOF MS in linear mode, and a
42 Da mass increment was con¢rmed by nanoESI Q-TOF MS
(data not shown).
3.2. RB3SLD and RB3PSLD are acetylated on their N-terminal
group
To demonstrate that RB3SLD and RB3PSLD are actually
acetylated, as well as to determine the modi¢ed positions
(which could be either the K-amino or a lysine O-amino
group), we submitted the proteins to tryptic proteolysis and
analyzed the resulting peptide mixtures by MALDI-TOF MS.
The peptide mass mapping covered more than 90% of each
protein sequence. In both cases, only traces of the non-modi-
¢ed N-terminal peptide 2^11 could be detected (mass-to-
charge ratio, m/z 1161.50), whereas an ion at m/z 1203.50
was consistently detected (note that we use a residue number-
ing including N-terminal methionine, although it is not
present in the mature proteins). By nanoESI Q-TOF MS/
MS, this ion was shown to correspond to peptide 2^11 acety-
lated on the N-terminal alanine (Fig. 1A,B for RB3SLD, not
shown for RB3PSLD) and not to peptide 134^142 from RB3SLD
(theoretical mass 1203.63), since no fragment ion correspond-
ing to this sequence was identi¢ed in the MS/MS spectrum.
Consistently, a less intense peak with an additional 16 Da
increment (m/z 1219.50) was often detected and identi¢ed by
tandem mass spectrometry as the acetylated peptide 2^11 with
a sulfoxide methionine.
The NK-acetylation of RB3SLD and RB3PSLD was further
con¢rmed by N-terminal sequencing on equimolar mixtures
of either RB3SLD or RB3PSLD with stathmin. As the N-termi-
nus of stathmin is not modi¢ed and has a di¡erent sequence,
comparing the yield of RB3SLD (respectively RB3PSLD) residue
obtained at each cycle with the corresponding yield of stath-
min residue provides a quantitative estimation for the amount
of N-terminally blocked RB3SLD (respectively RB3PSLD). In
that way, 86% RB3SLD and 91% RB3PSLD were estimated to
be blocked (data not shown). Altogether, our results demon-
strate that about 90% RB3SLD or RB3PSLD expressed in E. coli
is NK-acetylated.
3.3. Mutation of residues 7 and 8 reverses the acetylation
pattern of SCG10SLD and RB3SLD
NK-acetylation of proteins is thought to be driven by the
nature of their N-terminal residues, at least in eukaryotes. It
was thus striking that RB3SLD and RB3PSLD were NK-acety-
lated, whereas SCG10SLD and SCLIPSLD were not, although
these four proteins have the same N-terminal sequence up to
residue 6 (see Table 1). We thus tested whether exchanging
N-terminal residues between SCG10SLD and RB3SLD may
change their respective NK-acetylation. We expressed two mu-
Table 1
Calculated mass, MALDI-TOF MS experimental mass, di¡erence between experimental and calculated mass (in Da), and N-terminal sequence
of SLDs expressed in E. coli
Name Calculated massa Experimental mass vm N-terminal sequence
Stathmin 17 171.3 17 172.0 0.7 MASSDIQVKELE KRASGQAFELT
SCG10SLD 16 346.7 16 347.5 0.8 MA--DMEVKQIN KRASGQAFELT
SCLIPSLD 16 723.8 16 723.2 30.6 MA--DMEVKQLD KRASGQSFEVT
RB3SLD 16 679.9 16 722.9 43.0 MA--DMEVIELN KCTSGQSFEVT
RB3PSLD 15 023.1 15 067.0 43.9 MA--DMEVIELN KCTSGQSFEVT
aWithout N-terminal methionine.
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Fig. 1. A: MALDI-TOF mass spectrum of peptides resulting from RB3SLD tryptic proteolysis (insert: high m/z part of the spectrum). The
N-terminal peptides are in bold. B: Tandem mass spectrum resulting from fragmentation of the ion at m/z=1203.50, corresponding to the ace-
tylated RB3SLD peptide 2^11 (boxed in A). The scale factor applied to amplify some regions of the spectrum is indicated at the top of the pan-
el. The major y fragments (obtained from the C-terminal end) and b fragments (obtained from the N-terminal end) were identi¢ed by compari-
son with the calculated masses of the theoretical fragments, and the deduced sequence is indicated (N-terminus circled). Fragments
corresponding to individual amino acids are also indicated, as well as z fragments (asterisks).
Fig. 2. MALDI-TOF mass spectra of peptides resulting from proteolysis of SCG10SLD by trypsin (A), SCG10SLD-IE by trypsin (B), and
RB3SLD-KQ by GluC (C). Circles indicate sodium adducts. The N-terminal peptides are in bold. Tandem mass spectra resulting from fragmen-
tation of the corresponding N-terminal peptides (boxed), showing that SCG10SLD-IE is NK-acetylated (E), whereas SCG10SLD (D) and
RB3SLD-KQ (F) are not. Peaks corresponding to major fragmentation products (y and b series) are indicated, as well as internal fragments (by
their sequence), z fragments (asterisks), and loss of water (arrows). The deduced sequence is indicated (N-terminus circled).
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tant proteins: SCG10SLD-IE, in which residues 7 and 8 (KQ)
have been mutated into IE (residues 7 and 8 of RB3SLD), and
RB3SLD-KQ, in which residues 7 and 8 (IE) have been mu-
tated into the corresponding residues of SCG10SLD (KQ).
The experimental molecular masses of the mutant proteins,
measured by mass spectrometry, suggested that SCG10SLD-IE
was acetylated, whereas RB3SLD-KQ was not (Table 2). In-
deed, a tryptic digest of SCG10SLD-IE contained an ion at m/z
1359.70, as measured by MALDI-TOF MS, which was shown
by nanoESI Q-TOF MS/MS to correspond to SCG10SLD-IE
peptide 2^12 acetylated on its N-terminal alanine (Fig. 2C,F).
We similarly con¢rmed that the non-mutated protein
SCG10SLD was not acetylated: an ion at m/z 1331.69 was
detected by MALDI-TOF MS in a corresponding tryptic di-
gest, and was shown by nanoESI Q-TOF MS/MS to corre-
spond to the unacetylated peptide 2^12 (Fig. 2A,D). For the
mutant protein RB3SLD-KQ, the N-terminal peptide could not
be detected in the tryptic peptide mass map obtained by
MALDI-TOF MS. However, the analysis of a limited GluC
digest revealed a peak corresponding to the unacetylated pep-
tide 2^19 (m/z 2015.17), as was also veri¢ed by nanoESI
Q-TOF MS/MS (Fig. 2B,E).
Altogether, our results show that exchanging residues 7 and
8 between SCG10SLD and RB3SLD is su⁄cient to inverse their
N-terminal acetylation pattern, which suggests that the nature
of residues within the N-terminal region strongly determines
NK-acetylation also in prokaryotes.
4. Discussion
We report the NK-acetylation pattern of ¢ve mammalian
stathmin-like subdomains expressed in E. coli. We show that
despite the strong resemblance between these proteins, only
two of them are NK-acetylated, and that directed mutagenesis
of residues 7 and 8 in one acetylated and one unacetylated
protein reverses their acetylation pattern.
Whereas the cleavage of the N-terminal methionine was
expected (since second encoded residues are alanines), the
acetylation of the K-amino group was not. Indeed, NK-acety-
lation is very rare in E. coli, being described to our knowledge
for ¢ve proteins: the three ribosomal subunits L7/L12, S5, S18
[9,10], the elongation factor EF-Tu [11], and very likely the
chaperone SecB [12]. Moreover, ectopic proteins recombi-
nantly expressed in E. coli are frequently reported not to be
acetylated (in contrast to their endogenous NK-acetylation in
eukaryotes) or only very partially [15,16].
We analyzed to what extent the NK-acetylation pattern of
the SLDs expressed in E. coli could match previous knowl-
edge of NK-acetylation rules in eukaryotes. First, the NK-ace-
tylated residue in RB3SLD, RB3PSLD and SCG10SLD-IE is an
alanine, which is with serine one of the residues most fre-
quently acetylated in eukaryotes. Similarly, E. coli proteins
S5 and S18 are acetylated on an alanine, whereas L7/L12,
EF-Tu and possibly SecB are acetylated on a serine. More-
over, downstream residues in the N-terminal region have been
shown to in£uence NK-acetylation in eukaryotes [7,8]. We
show here that residues 7 and 8 of RB3SLD and RB3PSLD
have a primary in£uence on their NK-acetylation in E. coli,
since exchange of these two residues between unacetylated
SCG10SLD and acetylated RB3SLD reverses their acetylation
pattern. As the nature of residues 7 and 8 is su⁄cient to
switch the acetylation state, the observed modi¢cation seems
strongly dependent on sequence speci¢city. Yet, as the SLDs
share 80% of their amino acids, other residues may contribute
to NK-acetylation, particularly among the ¢rst six identical
ones.
We also examined the presence in SLDs of residues specif-
ically enriched or excluded from the N-terminus of acetylated
proteins [17]. NK-acetylated proteins display an overrepresen-
tation of acidic residues at positions 2 and 4, which is the case
for SLDs (excepted stathmin). NK-acetylated proteins also dis-
play an overrepresentation of lysine and isoleucine in their
N-terminal region. An isoleucine is found at position 7 in
the acetylated SLDs (RB3SLD, RB3PSLD, SCG10SLD-IE),
whereas a lysine is found at the same position in the non-
acetylated ones (SCG10SLD, SCLIPSLD, RB3SLD-KQ). Thus,
although the residues present in the N-terminal region of the
SLDs are roughly compatible with NK-acetylation, the di¡er-
ence due to residues 7 and 8 is not explained by the statistical
study. However, NK-acetylation is likely to be in£uenced not
only by residues with a positive e¡ect, but also by residues
with a negative inhibitory e¡ect [18]. In our case, either IE
residues have a positive e¡ect or KQ residues have an inhib-
itory in£uence. Further analysis of NK-acetylation determi-
nants of SLDs in E. coli may provide new insights into the
rules governing this modi¢cation.
The di⁄culty to determine NK-acetylation rules may also
come from the existence of various acetylation enzymes with
di¡erent speci¢city requirements. Indeed, in E. coli, three NK-
acetyltransferases have already been identi¢ed, namely rimI,
rimJ, rimL, each being responsible for the modi¢cation of a
di¡erent protein, S18, S5 and L12/L7, respectively [9,10].
SLDs may be modi¢ed by one of these enzymes, or by an-
other one, still unidenti¢ed. But the lack of sequence homol-
ogy of the SLDs in their N-terminal region with any protein
from E. coli does not give any clue to this question.
Altogether, our results demonstrate that NK-acetylation can
occur in E. coli, even on ectopic overexpressed proteins.
Although some general rules governing NK-acetylation seem
to be conserved between prokaryotes and eukaryotes, it is still
impossible to predict that a protein is NK-acetylated. Never-
theless, NK-acetylation has been demonstrated in some cases
to be important for protein activity. For example, unacety-
lated muscle K-tropomyosin expressed in E. coli polymerizes
poorly, and binds weakly to F-actin [19]. Similarly, unacety-
lated rat glycine M-methyltransferase expressed in E. coli does
Table 2
N-terminal sequence, calculated mass, experimental mass as measured by MALDI-TOF MS, and di¡erence between experimental and calcu-
lated mass (in Da) for the mutant proteins SCG10SLD-IE and RB3SLD-KQ
Name N-terminal sequence Calculated massa Experimental mass vm
SCG10SLD-IE MADMEVIEIN KRASGQAFELT 16 332.7 16 377.0 44.3
RB3SLD-KQ MADMEVKQLN KCTSGQSFEVT 16 693.9 16 694.6 0.7
aWithout N-terminal methionine.
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not exhibit the cooperative behavior of the native enzyme [20].
The way by which NK-acetylation in£uences speci¢c interac-
tions with protein partners may be the neutralization of the
N-terminus positive charge. Such an e¡ect may also in£uence
the correct folding of polypeptides during synthesis in other
cases. A practical consequence of our results is that each
recombinant protein expressed in ectopic cells should be care-
fully characterized by mass spectrometry at the protein level,
as is currently done at the nucleic level, since modi¢cations
can occur extensively even in E. coli, thereby modifying the
properties and homogeneity of protein preparations used in
long time consuming functional studies.
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